ClearPoint Neuro, Inc. (CLPT)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 56 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. (NASDAQ: CLPT) develops and commercializes medical devices for minimally invasive brain surgery guided by real-time MRI, centered on tools that help clinicians place instruments and therapies inside the brain. In FY2025, the company generated $37.0 million in revenue.
Today's Snapshot
The session opened with CLPT 2.2% lower at 13.57, while its sector was flat.
Trading Volume
Below 10d avg (519.7K)
37.6K
vs S&P 500 Today
Underperforming Market
-1.30%
Updated: September 10, 2026 at 14:35 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$14.36 - $14.86Sell
- RSI (14)37.76Neutral
- Stochastic %K (14, 3, 3)9.90Buy
- MACD Level (12, 26)-0.35Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.